Q2 2024 Holdings
Filed 2025-02-13 | 15 holdings | $232.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Denali Therapeutics Inc.(DNLI) | COM | 24823R105 | $97.9M | 4,214,559 | 42.1% |
| HilleVax, Inc. | COM | 43157M102 | $97.2M | 6,724,000 | 41.9% |
| Phathom Pharmaceuticals, Inc.(PHAT) | COM | 71722W107 | $16.0M | 1,557,063 | 6.9% |
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $6.7M | 1,346,892 | 2.9% |
| Ovid Therapeutics Inc.(OVID) | COM | 690469101 | $5.8M | 7,531,996 | 2.5% |
| Turnstone Biologics Corp. | COM | 90042W100 | $2.3M | 895,824 | 1.0% |
| Shattuck Labs, Inc.(STTK) | COM | 82024L103 | $2.0M | 515,619 | 0.9% |
| Xilio Therapeutics, Inc.(XLO) | COM | 98422T100 | $1.4M | 1,475,121 | 0.6% |
| Equillium, Inc.(EQ) | COM | 29446K106 | $1.3M | 1,824,977 | 0.5% |
| Rani Therapeutics Holdings, Inc.(RANI) | COM CL A | 753018100 | $817.7K | 215,172 | 0.4% |
| American Well Corp(AMWL) | COM CL A NEW | 03044L204 | $505.3K | 1,554,669 | 0.2% |
| Akili, Inc. | COMMON STOCK | 00974B107 | $321.4K | 738,819 | 0.1% |
| Standard Biotools Inc.(LAB) | COM | 34385P108 | $29.2K | 16,515 | 0.0% |